Spirometry is the measurement of air flow into and out of the lungs.
Spirometry requires that the nose is pinched off as the patient breathes through a mouthpiece attached to the spirometer. The patient is instructed on how to breathe during the procedure. Three breathing maneuvers are practiced before recording the procedure, and the highest of three trials is used for evaluation of breathing. This procedure measures air flow by electronic or mechanical displacement principles, and uses a microprocessor and recorder to calculate and plot air flow.
The test produces a recording of the patient's ventilation under conditions involving both normal and maximal effort. The recording, called a spirogram, shows the volume of air moved and the rate at which it travels into and out of the lungs. Spirometry measures several lung capacities. Accurate measurement is dependent upon the patient's performing the appropriate maneuver properly. The most common measurements are:
Normal values for FVC, FEV, FEF, and MVV are dependent on the patient's age, gender, and height.
Spirometry is the most commonly performed pulmonary function test (PFT). The test can be performed at the bedside, in a physician's office, or in a pulmonary laboratory. It is often the first test performed when a problem with lung function is suspected. Spirometry may also be suggested by an abnormal x ray, arterial blood gas analysis, or other diagnostic pulmonary test result. The National Lung Health Education Program recommends that regular spirometry tests be performed on persons over 45 years old who have a history of smoking. Spirometry tests are also recommended for persons with a family history of lung disease, chronic respiratory ailments, and advanced age.
Spirometry measures ventilation, the movement of air into and out of the lungs. The spirogram will identify two different types of abnormal ventilation patterns, obstructive and restrictive.
Common causes of an obstructive pattern are cystic fibrosis, asthma, bronchiectasis, bronchitis, and emphysema. These conditions may be collectively referred to by using the acronym CABBE. Chronic bronchitis, emphysema, and asthma result in dyspnea (difficulty breathing) and ventilation deficiency, a condition known as chronic obstructive pulmonary disease (COPD). COPD is the fourth leading cause of death among Americans.
Common causes of a restrictive pattern are pneumonia, heart disease, pregnancy, lung fibrosis, pneumothorax (collapsed lung), and pleural effusion (compression caused by chest fluid).
Obstructive and restrictive patterns can be identified on spirographs using both a "y" and "x" axis. Volume (liters) is plotted on the y-axis versus time (seconds) on the x-axis. A restrictive pattern is characterized by a normal shape showing reduced volumes for all parameters. The reduction in volumes indicates the severity of the disease. An obstructive pattern produces a spirogram with an abnormal shape. Inspiration volume is reduced. The volume of air expelled is normal but the air flow rate is slower, causing an elongated tail to the FVC.
A flow-volume loop spirogram is another way of displaying spirometry measurements. This requires the FVC maneuver followed by a forced inspiratory volume (FIV). Flow rate in liters per second is plotted on the y-axis and volume (liters) is plotted on the x-axis. The expiration phase is shown on top and the inspiration phase on the bottom. The flow-volume loop spirogram is helpful in diagnosing upper airway obstruction, and can differentiate some types of restrictive patterns.
Some conditions produce specific signs on the spirogram. Irregular inspirations with rapid frequency are caused by hyperventilation associated with stress. Diffuse fibrosis of the lung causes rapid breathing of reduced volume, which produces a repetitive pattern known as the penmanship sign. Serial reduction in the FVC peaks indicates air trapped inside the lung. A notch and reduced volume in the early segments of the FVC is consistent with airway collapse. A rise at the end of expiration is associated with airway resistance.
Spirometry is used to assess lung function over time, and often to evaluate the efficacy of bronchodilator inhalers such as albuterol. It is important for the patient to refrain from using a bronchodilator prior to the evaluation. Spirometry is performed before and after inhaling the bronchodilator. In general, a 12% or greater improvement in both FVC and FEV-1, or an increase in FVC by 0.2 liters, is considered a significant improvement for an adult patient.
The patient should inform the physician of any medications he or she is taking, or of any medical conditions that are present; these factors may affect the validity of the test. The patient's smoking habits and history should be thoroughly documented. The patient must be able to understand and respond to instructions for the breathing maneuvers. Therefore, the test may not be appropriate for very young, unresponsive, or physically impaired persons.
Spirometry is contraindicated in patients whose condition will be aggravated by forced breathing, including:
The test should be terminated if the patient shows signs of significant head, chest, or abdominal pain while the procedure is in progress.
Spirometry is dependent upon the patient's full compliance with breathing instructions, especially his or her willingness to extend a maximal effort at forced breathing. Therefore, the patient's emotional state must be considered.
The patient's age, gender, and race are recorded, and height and weight are measured before the procedure begins. The patient should not have eaten heavily within three hours of the test. He or she should be instructed to wear loose-fitting clothing over the chest and abdominal area. The respiratory therapist or other testing personnel should explain and demonstrate the breathing maneuvers to the patient. The patient should practice breathing into the mouthpiece until he or she is able to duplicate the maneuvers successfully on two consecutive attempts.
In most cases, special care is not required following spirometry. Occasionally, a patient may become lightheaded or dizzy. Such patients should be asked to rest or lie down, and should not be discharged until after the symptoms subside. In rare cases, the patient may experience pneumothorax, intracranial hypertension, chest pain, or uncontrolled coughing. In such cases, additional care directed by a physician may be required.
The results of spirometry tests are compared to predicted values based on the patient's age, gender, and height. For example, a young adult in good health is expected to have the following FEV values:
In general, a normal result is 80–100% of the predicted value. Abnormal values are:
Braunwald, Eugene et al., editors. Harrison's Principles of Internal Medicine. Philadelphia: McGraw-Hill, 2001.
Blonshine, S. and J.B. Fink. "Spirometry: Asthma and COPD Guidelines Creating Opportunities for RTs." AARC Times (January 2000): 43-7.
National Lung Health Education Program (NLHEP). 1850 High Street, Denver, CO 80218. http://www.nlhep.org .
Gary, T., et al. "Office Spirometry for Lung Health Assessment in Adults: A Consensus Statement for the National Lung Health Education Program." (March 2000): 1146-61.
National Institutes of Health. [cited April 4, 2003] http://www.nlm.nih.gov/medlineplus/encyclopedia.html .
"Spirometry—AARC Clinical Practice Guide." American Association for Respiratory Care. 1130 Ables Lane, Dallas, TX 75229. [cited April 4, 2003] http://www.muhealth.org/~shrp/rtwww/rcweb/aarc/spirocpg.html .
Robert Harr Paul Johnson Mark A. Best
children under 5 difficult to diagnose due to inability to correctly follow instructions
My FEV1 is in 80s, which is considered "mild" obstruction. Well folks, I have diffuse (throughout) bronchiectasis in both lungs as a result of either living in a sick house or miscroaspiration. 'Still trying to figure out how diffuse bronch. could be caused by microaspiration. I can see damage to the proximal airways, but not those located on the periphery of the lungs.
At any rate, although my obstruction is considered "mild," I have air trapping occurring daily, as well as extreme muscle fatigue. I would assume the muscle fatigue is a result of the oxygen exchange somehow being affected by the bronchiectasis.
Another point I'd like to make. Prior to the damage to my lungs, I was as healthy as a horse. I had never smoked, ran track in college, and was the appropriate weight for a person of my height. IMO, my FEV1 could have very well normally been at 120 or 130% of the "normal" value. Maybe even higher. The point is, if your normal FEV were in the 130% range, a reading in the high 80s represents a significant reduction in airflow. Close to a 1/3 loss of my airflow. At very least, the loss is significant enough to cause substantial muscle fatigue.
Oh, and BTW, I'd like to thank the quack pulmonologists in Kansas City that told me that mold exposure has NEVER caused long-term damage to anyone. I asked them if I should get out of the house, and they told me it can't cause damage. Well folks, 6 years later and I struggle to get a deep breath with every breath. How's that for a nice existence? A big thank you to the dumbass Pulmonology group at St. Lukes. F**king quacks!
Did you ever get a response to your question? If so, I'd like to know the answer. My spirometry results were almost exactly the same.
Does the CHF(congestive heart failure)increase the DLco or decrease it ?
healthy nonsmoking female. Is this a pre indicator for disease or am I freaking out? Can this number flucuate? I was apprehensive breathing the gas in so cold I have done it wrong? I should add I have horrible anxiety that also cause reflux
MY question is: 1) is it possible to increase The FVC % till to normal range? As I can see it is lower than normal 80%, which indicates restrictive lung disses. 2) Is there any treatment to stop the decline of FVC% 2) do I require further more investigation? 3) How severe my situation is according the above mentioned info? Do I need further more diagnosis?